In addition to traditional staining techniques, immunohistochemistry (IHC) is often employed. IHC uses antibodies to detect specific proteins expressed by cancer cells, providing additional information on the phenotype of the tumor. This can be crucial for identifying targeted therapies and predicting response to treatment.
